CoChat

Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia

Shurtleff, SA, Meyers, S, Hiebert, SW, Raimondi, SC, Head, DR, Willman, CL, Wolman, S, Slovak, ML, Carroll, AJ, Behm, F · 1995 · Blood

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Inv(16)(p13q22) is one of the most frequent chromosomal rearrangements found in acute myelogenous leukemia (AML), representing approximately 16% of documented karyotypic abnormalities. The inv(16) breakpoints have been cloned and shown to involve the non-DNA binding component of the AML-1 transcription factor complex termed core binding factor beta gene (CBF beta) on 16q and the smooth muscle myosin heavy chain gene (MYH11) on 16p. In this study, we analyzed 37 cases of inv(16)-containing AML and 4 cases with t(16;16)(p13;q22) for expression of the CBF beta/MYH11 chimeric message by reverse transcription-polymerase chain reaction (PCR) analysis. CBF beta/MYH11 chimeric messages were detected in 33 of 37 cases with the inv(16) and in the 4 t(16;16)-containing cases. Sequence analysis of PCR products showed extensive breakpoint heterogeneity in both CBF beta and MYH11. In addition to the previously described breakpoint in CBF beta at nucleotide (nt) 495 (amino acid 165), we have identified a second novel fusion point at nt 399 (amino acid 133) in 7% of the cases. Similarly, a unique breakpoint site was identified in MYH11 at nt 1098, as well as at three previously characterized sites at nts 994, 1201, and 1921. Of the 4 PCR-negative cases, 2 of 3 tested lacked CBF beta rearrangements by Southern blot analysis, suggesting the possible involvement of a different genomic locus in some cases with cytogenetic evidence of inv(16). To assess whether the portions of CBF-beta contained within the CBF beta/MYH11 chimeric products retain the ability to interact with their heterodimeric DNA-binding partner AML-1, we performed in vitro DNA- binding analysis. Recombinant CBF-beta polypeptides consisting of the N-terminal 165 amino acids retained their ability to interact with AML-1, whereas mutants containing only the N-terminal 133 amino acids interacted with AML-1 less efficiently. These data suggest that different CBF beta/MYH11 products may vary subtly in their biologic activities.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood.v85.12.3695.bloodjournal85123695

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Cited by

See all 102

Metadata

Authors
Shurtleff, S., Meyers, S., Hiebert, S., Raimondi, S., Head, D., Willman, C., Wolman, S., Slovak, M., Carroll, A., & Behm, F.
Affiliations
  • St. Jude Children's Research Hospital (US)
  • Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Venue
Blood
Published
1995-06-15
Volume
85
Issue
12
Pages
3695-3703
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1533510727
Cited by
102
References
23
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2022: 1 · 2021: 2 · 2019: 2 · 2017: 1 · 2015: 2 · 2014: 1 · 2013: 3 · 2012: 5
FWCI
4.66
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5k08ca001429-05)
  • National Cancer Institute (CA64140, CA-32102, U10CA032102, R01CA064140, CA 01429)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
CBFβ, MYH11, inv(16)(p13q22), acute myeloid leukemia, fusion transcripts, core binding factor beta, myosin heavy chain, DNA-binding activity, AML1-ETO fusion
MeSH terms
Adolescent, Adult, Aged, Amino Acid Sequence, Base Sequence, Child, Child, Preschool, Chromosome Aberrations, Chromosomes, Human, Pair 22, Cloning, Molecular, DNA-Binding Proteins, Female, Humans, Male, Middle Aged, Molecular Sequence Data, Myosins, Neoplasm Proteins, Recombinant Fusion Proteins, Transcription Factors, Leukemia, Myeloid, Acute, Core Binding Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. https://app.cochat.ai/papers/10.1182/blood.v85.12.3695.bloodjournal85123695
The paper
Shurtleff, S., Meyers, S., Hiebert, S., Raimondi, S., Head, D., Willman, C., Wolman, S., Slovak, M., Carroll, A., & Behm, F. (1995). Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Blood. https://doi.org/10.1182/blood.v85.12.3695.bloodjournal85123695

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.